Free Trial

Maven Income and Growth VCT 4 (MAV4) Competitors

GBX 56.50 -1.00 (-1.74%)
(As of 12/20/2024 09:50 AM ET)

MAV4 vs. LIO, JUSC, BGEU, JAGI, JPS, WPCT, BGHS, BIOG, EAT, and CGL

Should you be buying Maven Income and Growth VCT 4 stock or one of its competitors? The main competitors of Maven Income and Growth VCT 4 include Liontrust Asset Management (LIO), JPMorgan US Smaller Companies (JUSC), Baillie Gifford European Growth Trust (BGEU), JPMorgan Asia Growth & Income (JAGI), JPMorgan Japan Small Cap Growth & Income plc (JPS.L) (JPS), Woodford Patient Capital Trust (WPCT), Boussard & Gavaudan GBP (BGHS), The Biotech Growth Trust (BIOG), European Assets Trust (EAT), and Castelnau Group (CGL). These companies are all part of the "asset management" industry.

Maven Income and Growth VCT 4 vs.

Liontrust Asset Management (LON:LIO) and Maven Income and Growth VCT 4 (LON:MAV4) are both small-cap financial services companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, community ranking, analyst recommendations, institutional ownership, risk, media sentiment, profitability and valuation.

Liontrust Asset Management pays an annual dividend of GBX 72 per share and has a dividend yield of 15.8%. Maven Income and Growth VCT 4 pays an annual dividend of GBX 4 per share and has a dividend yield of 7.1%. Liontrust Asset Management pays out -144,000.0% of its earnings in the form of a dividend.

56.1% of Liontrust Asset Management shares are owned by institutional investors. 11.9% of Liontrust Asset Management shares are owned by company insiders. Comparatively, 1.3% of Maven Income and Growth VCT 4 shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Maven Income and Growth VCT 4 has lower revenue, but higher earnings than Liontrust Asset Management.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Liontrust Asset Management£197.89M1.48-£3.49M-£0.05-9,140.00
Maven Income and Growth VCT 4£2.65M29.11-£2.07MN/AN/A

In the previous week, Liontrust Asset Management had 1 more articles in the media than Maven Income and Growth VCT 4. MarketBeat recorded 1 mentions for Liontrust Asset Management and 0 mentions for Maven Income and Growth VCT 4. Liontrust Asset Management's average media sentiment score of 0.00 equaled Maven Income and Growth VCT 4'saverage media sentiment score.

Company Overall Sentiment
Liontrust Asset Management Neutral
Maven Income and Growth VCT 4 Neutral

Liontrust Asset Management has a beta of 1.33, suggesting that its stock price is 33% more volatile than the S&P 500. Comparatively, Maven Income and Growth VCT 4 has a beta of 0.15, suggesting that its stock price is 85% less volatile than the S&P 500.

Liontrust Asset Management currently has a consensus price target of GBX 485, suggesting a potential upside of 6.13%. Given Liontrust Asset Management's stronger consensus rating and higher possible upside, analysts plainly believe Liontrust Asset Management is more favorable than Maven Income and Growth VCT 4.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Liontrust Asset Management
0 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Maven Income and Growth VCT 4
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Liontrust Asset Management received 337 more outperform votes than Maven Income and Growth VCT 4 when rated by MarketBeat users. Likewise, 74.73% of users gave Liontrust Asset Management an outperform vote while only 67.62% of users gave Maven Income and Growth VCT 4 an outperform vote.

CompanyUnderperformOutperform
Liontrust Asset ManagementOutperform Votes
408
74.73%
Underperform Votes
138
25.27%
Maven Income and Growth VCT 4Outperform Votes
71
67.62%
Underperform Votes
34
32.38%

Liontrust Asset Management has a net margin of -1.76% compared to Maven Income and Growth VCT 4's net margin of -5.92%. Maven Income and Growth VCT 4's return on equity of -0.17% beat Liontrust Asset Management's return on equity.

Company Net Margins Return on Equity Return on Assets
Liontrust Asset Management-1.76% -1.78% 5.02%
Maven Income and Growth VCT 4 -5.92%-0.17%-0.11%

Summary

Liontrust Asset Management beats Maven Income and Growth VCT 4 on 13 of the 17 factors compared between the two stocks.

Get Maven Income and Growth VCT 4 News Delivered to You Automatically

Sign up to receive the latest news and ratings for MAV4 and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MAV4 vs. The Competition

MetricMaven Income and Growth VCT 4Asset Management IndustryFinancial SectorLON Exchange
Market Cap£77.14M£1.06B£3.69B£1.86B
Dividend Yield5.83%4.93%4.42%6.19%
P/E Ratio-3,100.00797.35419.531,797.43
Price / Sales29.112,095.572,223.64380,062.11
Price / Cash3.0763.8552.1628.19
Price / Book0.841.721.472.92
Net Income-£2.07M£64.60M£358.52M£156.26M
7 Day Performance-1.74%-1.92%-1.62%-1.92%
1 Month Performance-0.88%0.15%0.70%17.74%
1 Year Performance-7.38%7.37%9.93%29.21%

Maven Income and Growth VCT 4 Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MAV4
Maven Income and Growth VCT 4
N/AGBX 56.50
-1.7%
N/A-7.4%£77.14M£2.65M-3,100.00N/A
LIO
Liontrust Asset Management
0.8827 of 5 stars
GBX 490
-0.2%
GBX 485
-1.0%
-25.7%£313.16M£197.89M-9,820.00241
JUSC
JPMorgan US Smaller Companies
N/AGBX 501.32
-0.1%
N/A+17.8%£308.66M£17.06M2,642.11N/A
BGEU
Baillie Gifford European Growth Trust
N/AGBX 87.04
-0.9%
N/A-9.2%£307.61M£27.20M1,244.86N/ANews Coverage
Positive News
JAGI
JPMorgan Asia Growth & Income
N/AGBX 378.51
-1.4%
N/A+12.9%£306.55M£1.27M-7,680.00N/A
JPS
JPMorgan Japan Small Cap Growth & Income plc (JPS.L)
N/AGBX 561
-0.2%
N/AN/A£305.80M£-1,017,000.00-48.36N/A
WPCT
Woodford Patient Capital Trust
N/AGBX 33.60
-2.0%
N/AN/A£305.30M£56.03M5.33N/A
BGHS
Boussard & Gavaudan GBP
N/AGBX 2,420
+9,900.0%
N/AN/A£300.90M£-12,390,000.00-1,890.63N/AGap Up
BIOG
The Biotech Growth Trust
N/AGBX 936
-1.1%
N/A+2.5%£300.74M£80.35M457.00N/AInsider Trade
News Coverage
Positive News
High Trading Volume
EAT
European Assets Trust
N/AGBX 83.40
-0.2%
N/A-7.6%£300.30M£40.06M832.00N/ANews Coverage
CGL
Castelnau Group
N/AGBX 94
flat
N/A+24.5%£300.22M£1.99M-3,133.33N/ANews Coverage

Related Companies and Tools


This page (LON:MAV4) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners